A detailed history of Gleason Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Gleason Group, Inc. holds 352 shares of AMGN stock, worth $101,330. This represents 0.02% of its overall portfolio holdings.

Number of Shares
352
Previous 350 0.57%
Holding current value
$101,330
Previous $109,000 3.67%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $618 - $674
2 Added 0.57%
352 $113,000
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $788 - $957
3 Added 0.86%
350 $109,000
Q1 2024

Apr 12, 2024

BUY
$268.87 - $324.56 $806 - $973
3 Added 0.87%
347 $98,000
Q4 2023

Jan 19, 2024

BUY
$255.7 - $288.46 $511 - $576
2 Added 0.58%
344 $99,000
Q3 2023

Oct 12, 2023

BUY
$218.65 - $271.46 $655 - $814
3 Added 0.88%
342 $91,000
Q2 2023

Jul 20, 2023

BUY
$214.27 - $253.37 $642 - $760
3 Added 0.89%
339 $75,000
Q1 2023

Apr 14, 2023

BUY
$225.79 - $275.2 $451 - $550
2 Added 0.6%
336 $81,000
Q4 2022

Jan 11, 2023

BUY
$229.03 - $291.01 $687 - $873
3 Added 0.91%
334 $0
Q3 2022

Oct 11, 2022

BUY
$224.46 - $253.15 $673 - $759
3 Added 0.91%
331 $75,000
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $461 - $513
2 Added 0.61%
328 $80,000
Q1 2022

Apr 22, 2022

BUY
$219.27 - $242.57 $657 - $727
3 Added 0.93%
326 $79,000
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $397 - $455
2 Added 0.62%
323 $73,000
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $424 - $497
2 Added 0.63%
321 $68,000
Q2 2021

Jul 27, 2021

BUY
$233.58 - $259.14 $28,730 - $31,874
123 Added 62.76%
319 $78,000
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.51%
196 $49,000
Q1 2020

Aug 27, 2020

SELL
$182.24 - $241.7 $8,200 - $10,876
-45 Reduced 18.75%
195 $40,000
Q4 2019

Aug 27, 2020

BUY
$189.21 - $243.2 $45,410 - $58,368
240 New
240 $58,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gleason Group, Inc. Portfolio

Follow Gleason Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.